Latest headcount
31,500
YoY change
+12.5%
Headcount CAGR
+7.3%
Revenue / employee
$1.17M
Employee count history for Amgen
| Fiscal year | Employees |
|---|---|
| 1994 | 3,546 |
| 1995 | 4,046 |
| 1996 | 4,646 |
| 1997 | 5,308 |
| 1998 | 5,500 |
| 2000 | 7,300 |
| 2001 | 7,700 |
| 2002 | 10,100 |
| 2003 | 12,900 |
| 2004 | 14,400 |
| 2005 | 16,500 |
| 2006 | 20,100 |
| 2007 | 17,500 |
| 2008 | 16,900 |
| 2009 | 17,200 |
| 2010 | 17,400 |
| 2011 | 17,800 |
| 2012 | 18,000 |
| 2014 | 17,900 |
| 2015 | 17,900 |
| 2016 | 19,200 |
| 2017 | 20,800 |
| 2018 | 21,500 |
| 2019 | 23,400 |
| 2020 | 24,300 |
| 2021 | 24,200 |
| 2022 | 25,200 |
| 2023 | 26,700 |
| 2024 | 28,000 |
| 2025 | 31,500 |
Revenue per employee for Amgen
Annual revenue divided by reported headcount, normalized to US dollars.
| Fiscal year | Revenue per employee (USD) |
|---|---|
| 1994 | $457K |
| 1995 | $471K |
| 1996 | $473K |
| 1997 | $442K |
| 1998 | $480K |
| 2000 | $472K |
| 2001 | $522K |
| 2002 | $547K |
| 2003 | $648K |
| 2004 | $733K |
| 2005 | $753K |
| 2006 | $710K |
| 2007 | $844K |
| 2008 | $888K |
| 2009 | $851K |
| 2010 | $865K |
| 2011 | $875K |
| 2012 | $959K |
| 2014 | $1.12M |
| 2015 | $1.21M |
| 2016 | $1.2M |
| 2017 | $1.1M |
| 2018 | $1.1M |
| 2019 | $998K |
| 2020 | $1.05M |
| 2021 | $1.07M |
| 2022 | $1.04M |
| 2023 | $1.06M |
| 2024 | $1.19M |
| 2025 | $1.17M |
Earnings per employee for Amgen
Annual net income divided by reported headcount, normalized to US dollars; years with a net loss dip below zero.
| Fiscal year | Earnings per employee (USD) |
|---|---|
| 1994 | $90.2K |
| 1995 | $133K |
| 1996 | $146K |
| 1997 | $121K |
| 1998 | $157K |
| 2000 | $156K |
| 2001 | $145K |
| 2002 | -$138K |
| 2003 | $175K |
| 2004 | $164K |
| 2005 | $223K |
| 2006 | $147K |
| 2007 | $181K |
| 2008 | $248K |
| 2009 | $268K |
| 2010 | $266K |
| 2011 | $207K |
| 2012 | $241K |
| 2014 | $288K |
| 2015 | $388K |
| 2016 | $402K |
| 2017 | $95.1K |
| 2018 | $390K |
| 2019 | $335K |
| 2020 | $299K |
| 2021 | $244K |
| 2022 | $260K |
| 2023 | $252K |
| 2024 | $146K |
| 2025 | $245K |
Employee count history for Amgen (AMGN)
Annual figures come from annual reports (10-K, or 20-F/40-F for foreign filers); interim rows reflect headcount disclosed in periodic filings. Year-over-year change compares each filing with the prior year's equivalent. Revenue and earnings per employee are annual figures normalized to US dollars.
- 202531,500+12.5%
- 202428,000+4.9%
- 202326,700+6.0%
- 202225,200+4.1%
- 202124,200-0.4%
- 202024,300+3.8%
- 201923,400+8.8%
- 201821,500+3.4%
- 201720,800+8.3%
- 201619,200+7.3%
- 201517,9000.0%
- 201417,900—
- 201218,000+1.1%
- 201117,800+2.3%
- 201017,400+1.2%
- 200917,200+1.8%
- 200816,900-3.4%
- 200717,500-12.9%
- 200620,100+21.8%
- 200516,500+14.6%
- 200414,400+11.6%
- 200312,900+27.7%
- 200210,100+31.2%
- 20017,700+5.5%
- 20007,300—
- 19996,400—
- 19985,500+3.6%
- 19975,308+14.2%
- 19964,646+14.8%
- 19954,046+14.1%
- 19943,546—
About Amgen's employee count
Amgen (AMGN) employed 31,500 people in fiscal year 2025, based on its most recent annual report. That headcount grew by +3,500 (+12.5%) from 28,000 a year earlier.
Across the 1994–2025 period, the company's reported workforce went from 3,546 to 31,500 employees — a compound annual growth rate (CAGR) of +7.3% per year.
Amgen generated about $1.17M of revenue and $245K of net income per employee in its latest annual period. Revenue and earnings per employee gauge how efficiently a company turns headcount into output, and are most telling when tracked over time or compared with peers in the same industry.
Frequently asked questions
Test yourself on AMGN
Employees — 10 rounds, every one of them AMGN against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks
- Dividend Profile2.54% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.